Gossamer Bio, Inc. (GOSS) Financials

GOSS Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 128.9 million 290.4 million
Dec. 31, 2025 172.2 million 295.0 million
Sept. 30, 2025 208.8 million 291.2 million
June 30, 2025 240.9 million 287.0 million

GOSS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -38.7 million 6.3 million
Dec. 31, 2025 -48.3 million 2.9 million
Sept. 30, 2025 -36.2 million 2.7 million
June 30, 2025 -47.1 million 2.6 million

GOSS Net Income

No data available :(

GOSS Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 99.2 million 198.8 million 3.2 million
Dec. 31, 2025 136.9 million 202.0 million 4.4 million
Sept. 30, 2025 180.2 million 198.3 million 3.7 million
June 30, 2025 212.9 million 198.0 million 4.8 million

GOSS Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 234.1 million
Dec. 31, 2025 226.6 million
Sept. 30, 2025 228.0 million
June 30, 2025 227.3 million

GOSS Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 43.1 million 18.5 million -
Dec. 31, 2025 - 48.9 million 10.9 million -
Sept. 30, 2025 - 53.0 million 9.4 million -
June 30, 2025 53000 41.6 million 8.7 million -

GOSS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 17.0 million 232000
Dec. 31, 2025 13.8 million 227000
Sept. 30, 2025 13.3 million -
June 30, 2025 11.5 million -

GOSS Revenue by Segment
Graph available only for paid members. Upgrade to see it.

GOSS

Price: $0.17

52 week price:
0.16
3.87

Earnings Per Share: -0.79 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 916653

Market Capitalization: 44.5 million

Links: